Synapse - Barriers to immune effector cell therapy: Rapid disease progression, concern for toxicity, and lack of appropriate trials drive non-receipt after referral at a large academic center

Barriers to immune effector cell therapy: Rapid disease progression, concern for toxicity, and lack of appropriate trials drive non-receipt after referral at a large academic center Meeting Abstract

Authors:	Valtis, Y. K.; Chin, K. K.; Yisraeli Salman, M.; Boussi, L.; Cadzin, B.; McLoughlin, C.; Cathcart, E.; Davis, P.; Brooklyn, C.; Goldstein, T.; Famulare, C.; Shah, G. L.; Walji, M.; Boardman, A. P.; Shouval, R.; Stein, E. M.; Mailankody, S.; Palomba, M. L.; Salles, G.; Giralt, S.; Perales, M. A.; Park, J. H.
Abstract Title:	Barriers to immune effector cell therapy: Rapid disease progression, concern for toxicity, and lack of appropriate trials drive non-receipt after referral at a large academic center
Meeting Title:	66th Annual Meeting of the American Society of Hematology (ASH)
Journal Title:	Blood
Volume:	144
Issue:	Suppl. 1
Meeting Dates:	2024 Dec 7-10
Meeting Location:	San Diego, CA
ISSN:	0006-4971
Publisher:	American Society of Hematology
Date Published:	2024-11-05
Start Page:	781
End Page:	782
Language:	English
ACCESSION:	WOS:001412816800031
DOI:	10.1182/blood-2024-200915
PROVIDER:	wos
Notes:	Meeting Abstract -- Source: Wos